304 filings
Page 3 of 16
8-K
tayv0163
11 Aug 22
HTG Molecular Diagnostics Reports Second Quarter 2022 Results
4:16pm
8-K
q019fkob5wt48ok
18 Jul 22
Entry into a Material Definitive Agreement
8:30am
DEFA14A
gauv byu44
7 Jul 22
Additional proxy soliciting materials
4:15pm
8-K
4skzvpgkr1ddo1 himy3
27 Jun 22
Departure of Directors or Certain Officers
4:00pm
8-K
jlrldb4
9 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
8zhzhlhvn hnry0a7
12 May 22
HTG Molecular Diagnostics Reports First Quarter 2022 Results
4:21pm
EFFECT
28txbfc06dddmg0
20 Apr 22
Notice of effectiveness
12:15am
CORRESP
ubw5gs9y x4b
15 Apr 22
Correspondence with SEC
12:00am
UPLOAD
9vd guhbt
14 Apr 22
Letter from SEC
12:00am
8-K
1dk5t141
29 Mar 22
HTG Molecular Diagnostics Reports Full Year 2021 Results
4:10pm
D
xvlpdfhq3bx6
25 Mar 22
$20.88M in equity / options / securities to be acquired, sold $7.5M, 1 investor
4:10pm
8-K
tiupb
21 Mar 22
Unregistered Sales of Equity Securities
5:11pm
EFFECT
hr0rjx9h29hq
3 Feb 22
Notice of effectiveness
12:15am
UPLOAD
3tqrv jhgeiwfi8z
31 Jan 22
Letter from SEC
12:00am
CORRESP
l9j un95ytdvdndkk
31 Jan 22
Correspondence with SEC
12:00am